Trials in Long Beach, California
Here are the top 10 medical studies for depression in Long Beach, California
Popular Filters
Phase 3 Trials
Behavioural Intervention
Solriamfetol for Depression
Recruiting1 awardPhase 3
Sherman Oaks, California
This trial is testing solriamfetol, a medication that may help improve symptoms of depression. It targets adults with major depressive disorder (MDD) who do not have psychotic features. Solriamfetol works by affecting brain chemicals involved in mood regulation, potentially helping to improve mood and reduce depression symptoms.
NMRA-335140 for Depression
Recruiting2 awardsPhase 3
Long Beach, California
This trial is testing a new medication called NMRA-335140 to see if it helps people with major depressive disorder. It includes participants who have no safety concerns. The medication aims to improve mood by affecting brain chemicals.
Psychedelic
Psilocybin for Treatment-Resistant Depression
Recruiting1 awardPhase 3
Garden Grove, California
This trial is testing a new medication called COMP360 to help people with severe depression that hasn't improved with other treatments. The study involves adults aged 18 and older. Researchers want to see if a single dose of COMP360 can reduce depression symptoms when given with psychological support.
Aticaprant + Antidepressant for Depression
Recruiting1 awardPhase 3
Newport Beach, California
This trial aims to see if aticaprant is effective in preventing the return of depression symptoms when added to antidepressant therapy in individuals with major depressive disorder who have already responded well to aticaprant treatment
Behavioural Intervention
Lumateperone for Pediatric Bipolar Depression
Recruiting1 awardPhase 3
Anaheim, California
"This trial is studying the effectiveness of a new treatment for children with bipolar disorder who are also experiencing major depressive episodes. The study is being conducted at multiple locations and will involve random assignment of participants to receive
Behavioral Intervention
Cognitive Training for Mental Health Conditions
Recruiting0 awardsPhase 2 & 3
San Diego, California
This trial will test the effects of a computer-based cognitive training program on individuals with anxiety, depression, or traumatic stress symptoms. Participants will be split into two groups: one receiving the actual training program and
Trials With No Placebo
Brain Stimulation
rTMS for Depression
Recruiting1 award6 criteria
Los Angeles, California
"This trial aims to develop a personalized brain stimulation treatment for major depressive disorder using repetitive transcranial magnetic stimulation (rTMS). Researchers will compare different rTMS frequencies targeting a specific brain region in
Behavioral Intervention
Cognitive Behavioral Immersion for Depression
Recruiting1 award1 criteria
Los Angeles, California
"This trial will test a new cognitive-behavioral skills training program delivered in a virtual world called the metaverse. The program aims to help individuals with depression. Participants will be divided into three groups
Procedure
Mindfulness Neurostimulation for Depression
Recruiting1 awardPhase 2
La Jolla, California
"This trial aims to develop a new treatment for treatment-resistant depression by combining a type of magnetic stimulation with digital mindfulness training to improve cognitive functioning and alleviate depression symptoms in individuals who have not responded to traditional therapies
Behavioural Intervention
Heart Rate Variability Biofeedback for Depression
Recruiting1 awardPhase 2
Los Angeles, California
This trial aims to study different subtypes of depression by looking at how people regulate their emotions and their physiological responses. The study involves assessing affect, regulation strategies, and physiological activity in young adults with depression
NMRA-335140 for Depression
Recruiting2 awardsPhase 3
Long Beach, California
This trial is testing a new medication called NMRA-335140 to see if it helps people with major depressive disorder. It includes participants who have no safety concerns. The medication aims to improve mood by affecting brain chemicals.
Behavioural Intervention
Pramipexole vs Escitalopram for Depression in HIV
Recruiting1 awardPhase 2
Torrance, California
This trial is comparing the safety and effectiveness of two different medications, pramipexole extended release and escitalopram, for treating major depressive disorder (MDD) in people with HIV.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.